Is $APUS pump-proof?

Apimeds Pharmaceuticals US, Inc. — trap-risk read from social crowding, price extension, and SEC disclosure flags. Updated 2026-07-18.

$APUS
Apimeds Pharmaceuticals US, Inc.
CLEAR RISK
18
/ 100 trap score
Low trap risk right now: trading near its normal range with no major disclosure flags.
Hype / crowding
5
Run-up / extension
5
Structural risk
50
$8-K reporting unregistered share sales 8 months ago
3 more flags — filing links, dates, and the full breakdown.Pro — founding list open ↓
PumpProof · pumpproof.com
as of 2026-07-18 · not financial advice

The record on $APUS

first scored Jul 14 at $0.92 — -28% since
30Jul 14$0.92
18Jul 18$0.66
Every score we publish is snapshotted the day it runs — wins and misses stay on the record. Full ledger in the Friday email.
$APUS scored 18 today. Get the receipt when this call resolves.
One email, Fridays — every call's aging, wins and misses. Unsubscribe anytime. · or get pinged the moment the next one hits → Discord
PRO

The founding list is open

Founding members lock the lowest rate ever offered, dated from signup. No card needed today — you'll get first access when Pro opens.
Check any other ticker free at pumpproof.com

Get the Sunday watchlist before Monday's open

Every Sunday evening: the names heating up on weekend chatter before they hit this board, scored against their filings. Plus Friday receipts — how every score aged, wins and misses. Free, in your inbox.